In catalysis, inhibitors can either enhance or suppress the activity of a catalyst. Checkpoint inhibitors in biological systems, specifically in immunotherapy, serve to release the brakes on the immune system, allowing it to attack cancer cells more effectively. Analogously, in chemical catalysis, checkpoint inhibitors could be designed to regulate the active sites of catalysts, thereby fine-tuning the catalytic process.
